Literature DB >> 8484015

Epidermal growth factor interferes with the effect of adrenaline on glucose production and on hepatic lipase secretion in rat hepatocytes.

C Soler1, X Galan, J Peinado-Onsurbe, I Quintana, M Llobera, M Soley, I Ramírez.   

Abstract

We studied the interaction of epidermal growth factor (EGF) and adrenaline in the control of several metabolic functions in isolated hepatocytes from fed rats. EGF did not modulate glucose release, urea production or hepatic lipase secretion, but interfered with the stimulatory effect of adrenaline on both glucose and urea production and also with the inhibitory effect of this hormone on hepatic lipase secretion. EGF also interfered with the effect of both angiotensin II and vasopressin on glucose release and on hepatic lipase secretion. While the effect of EGF interfering with the action of adrenaline on glucose release was potentiated in the absence of extracellular calcium, the effect on the inhibition of hepatic lipase secretion was abolished. These results suggest that EGF interfered with catecholamine actions in the liver at a site distal from the generation of the calcium signal.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484015     DOI: 10.1016/0167-0115(93)90125-r

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  3 in total

1.  Maturation and secretion of rat hepatic lipase is inhibited by alpha1B-adrenergic stimulation through changes in Ca2+ homoeostasis: thapsigargin and EGTA both mimic the effect of adrenaline.

Authors:  B P Neve; A J Verhoeven; I Kalkman; H Jansen
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  The early stimulation of glycolysis by epidermal growth factor in isolated rat hepatocytes is secondary to the glycogenolytic effect.

Authors:  I Quintana; M Grau; F Moreno; C Soler; I Ramírez; M Soley
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

3.  Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone.

Authors:  M Klin; M Smogorzewski; Z Ni; G Zhang; S G Massry
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.